CorVel (CRVL) Competitors $89.76 -0.69 (-0.76%) Closing price 04:00 PM EasternExtended Trading$89.92 +0.16 (+0.18%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. DVA, CHE, AMED, MD, AMN, CCRN, LH, DGX, APG, and ULSShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), APi Group (APG), and UL Solutions (ULS). CorVel vs. Its Competitors DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics APi Group UL Solutions CorVel (NASDAQ:CRVL) and DaVita (NYSE:DVA) are both mid-cap health care services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations. Which has more risk and volatility, CRVL or DVA? CorVel has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, DaVita has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Which has preferable earnings and valuation, CRVL or DVA? DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorVel$895.59M5.14$95.17M$1.9446.27DaVita$13.16B0.75$936.34M$10.1713.63 Is CRVL or DVA more profitable? CorVel has a net margin of 10.98% compared to DaVita's net margin of 6.35%. DaVita's return on equity of 369.39% beat CorVel's return on equity.Company Net Margins Return on Equity Return on Assets CorVel10.98% 32.31% 18.33% DaVita 6.35%369.39%4.62% Do insiders and institutionals believe in CRVL or DVA? 51.4% of CorVel shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 44.6% of CorVel shares are owned by company insiders. Comparatively, 1.5% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate CRVL or DVA? DaVita has a consensus price target of $164.00, indicating a potential upside of 18.31%. Given DaVita's stronger consensus rating and higher probable upside, analysts plainly believe DaVita is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DaVita 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media favor CRVL or DVA? In the previous week, DaVita had 3 more articles in the media than CorVel. MarketBeat recorded 18 mentions for DaVita and 15 mentions for CorVel. CorVel's average media sentiment score of 1.24 beat DaVita's score of 1.14 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 11 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 11 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDaVita beats CorVel on 9 of the 15 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$4.61B$5.70B$26.00B$9.76BDividend YieldN/A3.35%2.77%4.08%P/E Ratio46.2729.2828.3326.03Price / Sales5.141.81990.06193.91Price / Cash38.1516.4125.5828.79Price / Book14.324.946.776.08Net Income$95.17M$155.37M$197.91M$265.64M7 Day Performance0.28%1.59%11.86%3.11%1 Month Performance1.15%1.36%4.19%0.39%1 Year Performance-13.85%59.71%44.71%18.52% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel1.9483 of 5 stars$89.76-0.8%N/A-13.7%$4.61B$895.59M46.275,075News CoveragePositive NewsDVADaVita4.4602 of 5 stars$133.39-1.5%$164.00+22.9%-10.8%$9.68B$12.82B13.1276,000Positive NewsCHEChemed4.9872 of 5 stars$444.930.0%$579.75+30.3%-20.3%$6.49B$2.43B22.8815,695Positive NewsAMEDAmedisys3.0206 of 5 stars$101.01+0.0%$100.50-0.5%+3.5%$3.32B$2.40B39.3019,000Positive NewsMDPediatrix Medical Group2.0429 of 5 stars$15.99-0.3%$16.75+4.7%+50.4%$1.40B$2.01B12.404,305News CoveragePositive NewsAMNAMN Healthcare Services4.5056 of 5 stars$19.43+2.7%$28.25+45.4%-61.2%$725.09M$2.98B-2.502,968News CoverageCCRNCross Country Healthcare3.4404 of 5 stars$13.56+1.4%$17.93+32.2%-10.1%$438.03M$1.34B-52.158,205News CoverageLHLabcorp4.6528 of 5 stars$270.87+0.2%$289.58+6.9%+19.6%$22.47B$13.01B29.9070,000News CoveragePositive NewsAnalyst ForecastDGXQuest Diagnostics4.7803 of 5 stars$179.19-0.3%$186.00+3.8%+16.4%$20.10B$9.87B21.4656,000Trending NewsAnalyst DowngradeInsider TradeAPGAPi Group2.5802 of 5 stars$35.55+0.8%$36.10+1.5%+50.7%$14.67B$7.02B111.1029,000Positive NewsULSUL Solutions2.8775 of 5 stars$67.03-0.1%$70.86+5.7%+14.8%$13.48B$2.87B41.3815,094News CoveragePositive NewsDividend Announcement Related Companies and Tools Related Companies DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives LH Alternatives DGX Alternatives APG Alternatives ULS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBREAKING: Meta, Apple and NASA rush to invest in new "E.I." techBig Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access